CorMedix (CRMD) Capital Expenditures (2010 - 2025)
CorMedix (CRMD) posted Capital Expenditures of $1.7 million for Q4 2025, up 240.09% sequentially from $505774.0 in Q3 2025, and up 16865.22% YoY from N/an in Q4 2024.
CorMedix (CRMD) Capital Expenditures (2010 - 2025) Analysis & Trends
CorMedix has reported Capital Expenditures for 12 years, with the latest figure at $1.7 million in Q4 2025.
- Quarterly Capital Expenditures rose 16865.22% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (up 1848.28% YoY) and the FY2025 annual result came in at $2.3 million, up 1848.28% from the prior year.
- Capital Expenditures climbed to $1.7 million in Q4 2025 per CRMD's latest filing, from $505774.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.7 million in Q4 2025 and troughed at $4324.0 in Q1 2022.
- A 5-year average of $217399.4 and a median of $19355.5 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures sank 96.57% in 2024, then jumped 16865.22% in 2025.
- Over 5 years, Capital Expenditures stood at $628761.0 in 2021, then tumbled by 79.52% to $128755.0 in 2022, then soared by 129.84% to $295931.0 in 2023, then tumbled by 96.57% to $10139.0 in 2024, then surged by 16865.22% to $1.7 million in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $1.7 million, $505774.0, and $23945.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.72 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 505,774.00 |
| Sep 30, 2025 | 505,774.00 |
| Jun 30, 2025 | 23,945.00 |
| Jun 30, 2025 | 23,945.00 |
| Mar 31, 2025 | 10,177.00 |
| Mar 31, 2025 | 10,177.00 |
| Dec 31, 2024 | 10,139.00 |
| Dec 31, 2024 | 10,139.00 |
| Sep 30, 2024 | 9,766.00 |
| Sep 30, 2024 | 9,766.00 |
| Jun 30, 2024 | 34,789.00 |
| Jun 30, 2024 | 34,789.00 |
| Mar 31, 2024 | 61,306.00 |
| Mar 31, 2024 | 61,306.00 |
| Dec 31, 2023 | 295,931.00 |
| Dec 31, 2023 | 295,931.00 |
| Sep 30, 2023 | 10,245.00 |
| Sep 30, 2023 | 10,245.00 |